my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
07-02-2009: Saltigo GmbH targets Japanese custom manufacturing market, presenting its portfolio of services at Interphex/Pharma-i Japan Exhibition in Tokyo. Saltigo’s CEO Wolfgang Schmitz emphasizes: “This is Asia’s largest pharmaceutical industry event and has an excellent reputation for attracting key decision makers from the industry. The Asian market and Japan in particular is becoming increasingly important for Saltigo. We already enjoy a good level of business activity in Japan across all market sectors, especially those serving life science industries.”
Japan is well-known for its commitment to new technologies and innovative products. This coupled with extremely stringent demands for higher tier performance is perfectly in line with Saltigo’s strategy to expand service offerings to this market. Saltigo, the wholly-owned subsidiary of specialty chemicals company LANXESS, has completed a Euro 10 million investment in early 2008 for a facility focused on the production of advanced intermediates and active ingredients under CGMP (Current Good Manufacturing Practice). The unit based in Leverkusen/Germany has a total capacity of more than 200 metric tons per year and provides a high degree of flexibility in terms of reactor volumes which range from 2.5 to 8 cubic meters.
To complement commercial scale manufacturing capacity, LANXESS Corporation also operates a site for Saltigo in Redmond (Washington, United States) targeting the field of active ingredient research and projects in the pre-clinical and early clinical phases. Its initial capacity was expanded again during 2008, and extends in particular Saltigo's ability to meet growing outsourcing requirements.
Osaka-based Sota Kurita, Business Development Manager for Japan, comments: “With the globalization of today’s pharmaceutical business, a significant proportion of new drug candidate compounds created in Japan first undergo clinical testing in the US. It has therefore become increasingly important to have an investigational new drug supply site in the US that can offer not just FDA compliant manufacture but also comprehensive support in areas such as quality assurance and the regulatory registration process.”
Contact / Request information
Request further information free of charge:
Watchlist
This is where you can add this news to your personal favourites
LANXESS increases price level for Chloroprene Rubber
LANXESS announced a price increase for its Baypren branded Chloroprene business line of up to EUR 180 EUR / 240 USD per metric ton on a global basis. Reason being the since early 2012 again increasing raw material and energy prices amidst a tightening market for the respective feedstocks. S ... more
Former Lufthansa building renamed “LANXESS Tower”
Specialty chemicals company LANXESS will be able to welcome employees, customers and guests to the “LANXESS Tower” from the middle of next year. This is the new name chosen for the company's future headquarters on Deutzer Freiheit in Cologne. In summer 2011, LANXESS asked its employees to h ... more
LANXESS expands Jhagadia site to serve booming Indian market
LANXESS is continuing to expand its Indian production site in Jhagadia, Gujarat state. The specialty chemicals group is underlining its commitment to the subcontinent by inaugurating three new plants this month to serve the growing India market. LANXESS has invested over EUR 70 million and ... more
LANXESS is Germany’s largest listed specialty chemicals group and operates in all important markets of the world. Its core business comprises the development, manufacture and sale of high-tech plastics, high-performance rubber, specialty chemicals and intermediates. In addition, it helps it ... more
LANXESS is listed as the fourth largest German Chemistry Corporation in the Frankfurt Stock Exchange. With our extensive portfolio we are active in all the markets of the world. Our product pallet ranges from base, specialty and fine chemicals to plastics and rubbers. In addition, we sup ... more
LANXESS Sybron Chemicals Inc., provides world-class ion exchange resins to meet the needs of numerous applications. The global strength of Lewatit ion exchange resins in industrial water and chemical processing markets is joined with the solid position Ionac ion exchange resins enjoy in the ... more
New head of Saltigo’s Agro & Fine Chemicals business line
Effective February 1, 2012, Joerg Schneider, Managing Director of LANXESS Elastômeros do Brasil S.A., will assume management of the Agro & Fine Chemicals business line of Saltigo GmbH. The 49-year-old will succeed Dr. Uwe Brunk, who is leaving the company at his own request. Schneider began ... more
Saltigo focuses on palladium-catalyzed cross-coupling reactions
Palladium-catalyzed cross-coupling reactions have become an important cornerstone of modern organic synthesis chemistry. They have made a wide variety of active pharmaceutical ingredients, natural substances and other complex organic molecules economically accessible. The award of this year ... more
Joint separation: Cooperation will extend service offerings of LANXESS subsidiary
Saltigo GmbH, the specialist in custom synthesis based in Langenfeld, Germany, and Reuter Chemische Apparatebau KG (RCA) of Freiburg, Germany, concluded a cooperation agreement on October 1. The companies will jointly develop processes for the synthesis of active pharmaceutical ingredients ... more
Saltidin®- proven active ingredient for insect repellents
Saltidin® is a proven active ingredient for insect repellents. It protects against deadly diseases from mosquitoes, flies and ticks more
Saltigo GmbH is a globally operating custom manufacturing specialist, providing services in the pharmaceutical, agro- & specialty chemical industry. Saltigo combines the flexibility of a midsize company with the financial stability and coverage of a global player. With a comprehensive set ... more
About CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2011 CHEMIE.DE Information Service GmbH, All rights reserved
